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SCHROEDER LECTURE
WORST PILLS, BEST PILLSt
Sidney M Wolfeft
It is nice to be back here. I am also from Cleveland. Aside from
my connections with the city, I still, intermittently, teach at the Case
School of Medicine. I am an Adjunct Professor in the department of
Internal Medicine.
Tonight, I am going to really focus on our book, Worst Pills, Best
Pills, but more importantly, the principles in it that will, hopefully, be
useful to some of you in terms of your own health, or the health of
your children or parents, or whomever else. We originally published
this book in 1988 because, having written articles and done a certain
amount of work concerning prescription drug dangers, it seemed that
there was a need for a book that really called the shots where they
should be. So we titled the book Worst Pills, Best Pills. Originally, the
book listed about a hundred or so drugs that were worst pills and for,
every one of the worst pills, we listed the safer alternatives. It is now
greatly expanded. The book, I suppose, could be construed as an up-
per-body workout because it weighs four pounds or so. I gave a talk
on the book, somewhat like tonight's, at the YMHA in Manhattan,
last night. Barnes & Noble had set up this little place to sell the
books-and several people went up and said, I would like to buy the
book, but I do not want to carry it home. So, it was recommended that
they go to their nearby Barnes & Noble store. So, it is, at once, a
guide to dangerous drugs and also an upper-body workout, one arm at
a time, or both arms.
t Edited from the 2005 Schroeder Scholar in Residence Lecture sponsored
by the Law-Medicine Center at Case Western Reserve University School of Law on
November 16, 2005. The Schroeder Lecture is conducted on an annual basis. This
version has been edited for publishing purposes and does not contain the lecture in its
entirety. The full transcript is on file at the Law-Medicine Center and at the offices of
the Health Matrix: Journal of Law-Medicine (publisher's note). The information in
the book is now also available on the web site worstpills.org.
" MD, Western Reserve University School Medicine, 1965. Dr. Wolfe is the
Director of Public Citizen's Health Research Group.
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Why are we concerned about this problem? The following num-
bers are all from published studies and, if anything, they are probably
significantly larger now than they were at the time. Two million seri-
ous adverse drug reactions occur, yearly, just in this country. A hun-
dred-thousand deaths, adverse drug reaction deaths, and, I will repeat
this over and over again, mostly preventable. And, depending what
year it is, deaths from adverse reactions to drugs are between the
fourth and the sixth leading cause of death in the United States,
greatly exceeding automobile accidents, HIV, and other causes that
people believe to be more common. Economically, it accounts for
about $136 billion a year-again, these figures are several years old
so it is more than that by now. To the extent that it is preventable-
preventable deaths, preventable hospitalizations, about a million-and-
a-half people hospitalized every year because of an adverse drug reac-
tion-something should be done about it.
The purpose of the book, in parallel with our efforts to get the
FDA to ban or put stronger warnings on these drugs, is to try to en-
courage patients do something about it. In addition to the million-and-
a-half people I mentioned who are hospitalized because of adverse
drug reactions every year, another three-quarters of a million people,
who were fine when they came into the hospital, developed, in the
hospital, an adverse drug reaction. So the toll of adverse drug reac-
tions is enormous in terms of adverse affects on the public health.
Concerning emergency room visits, a recent review of all the
studies asked the question, how often does someone who goes to the
emergency room go there because of an adverse drug reaction? This
review found out that 28 percent of all emergency department visits
were drug-related including a large portion due to adverse drug reac-
tions and inappropriate prescriptions. Again, the point was 70 percent
were preventable.
When we first put out our book, Worst Pills, Best Pills, it simu-
lated some medical researchers to come up with lists of drugs that,
really, should not be used, specifically for older adults. They came up
with lists that were much shorter than ours because they wanted to be
absolutely clear, although we think ours are more than clear enough.
Some of these people have looked at national data and asked the ques-
tion, how many people, nationally, are taking one of these inappropri-
ate or potentially inappropriate drugs? In a fairly recent study 6.6 mil-
lion people a year were taking a potentially inappropriate drug. Now,
this is of a much smaller list than we have. It is, probably, twenty or
thirty drugs instead of the now 181 that we list in our book as "Do Not
Use." So overall, of the 181 drugs that we list in our book as "Do Not
Use" fifty-three or 29 percent are amongst the top selling two hundred
drugs. This is based on retail prescriptions filled in 2004. These fifty-
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three drugs cost $22.2 billion in 2004. Again, for every drug that is a
"Do Not Use" you can turn to another page in the book and find a
drug which is safer and often, an older drug.
This is just a very small example of some of the "Do Not Use"
drugs: sleeping pills like Valium, Restoril, Ativan, Tranxene; antide-
pressants such as Serzone, Elavil; painkillers, Vioxx would be on the
list except it is off the market. We warned people to stop using Vioxx
four-and-a-half years ago when it was clear, from a well-done study
funded by Merck, that it was causing a four-fold increase risk in heart
attacks. Darvon, Darvocet, basically worthless painkillers; addicting
and cause cardiac toxicity. The toenail fungus drug, Lamisil, probably
many of you have seen cartoons about little fungus things crawling
around people's toenails, making your toenails look ugly, which is a
cosmetic problem. The drug causes severe and often fatal liver toxic-
ity, rarely. But there are dozens, if not by now, hundreds of cases of
liver toxicity and to trade-off a cosmetic advantage for your toenails
for liver toxicity we do not think is a good idea, so it is listed as a "Do
Not Use" drug.
Other "Do Not Use" drugs include Crestor, the newest of the cho-
lesterol lowering drugs. Crestor is a drug we tried to keep off the mar-
ket. We did not succeed, but since it has been on the market we have
been attempting to get it taken off the market. I think it, eventually,
will come off the market. Others in this category of heart drugs are
Lopid, Catapres and more. "Do Not Use" gastrointestinal drugs in-
clude Donnatal, Librax. There are also several diabetes drugs and
birth control pills. And just last week, another birth control device, a
patch called OrthoEvra, has come under scrutiny. We actually warned
people to stop using it a couple years ago. It gives a much higher dose
of estrogen and causes a higher rate of blood clots than the older pills.
Three other birth controls also contain an ingredient, not the estrogen,
but the progesterone content of the pill, which causes increased blood
clots, so we say do not use those.
The list of thirty "Do Not Use" drugs including the ones just men-
tioned, have 228 million prescriptions a year filled, a cost of over $12
billion a year. In many of the most commonly prescribed categories of
drugs we discuss in the book: mind drugs (tranquilizers, sleeping pills,
antipsychotic drugs), heart drugs, gastrointestinal drugs, pain and ar-
thritis drugs, large proportions of them, respectively 43 percent, 20
percent, 31 percent and 37 percent are on our "Do Not Use" list.
We published in the Journal of the American Medical Association
about three years ago in which the question we were asking was:
What happens, on the average, to a drug once it comes on the market?
We looked at every new drug approved by the FDA between 1975 and
1999. There were 548 such drugs. We found that of the 548 new
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drugs, fifty-six had either been taken off the market or were the sub-
ject of a black box warning.
We concluded that by the time drugs have been on the market for
twenty-five years, one out of five drugs were either withdrawn or re-
quired a new black box warning. And most of this was in the first
seven years after approval.
Our conclusion from this and from other work is to recommend
that nobody use any new drug unless it is a breakthrough drug, of
which there are some but not very many. Specifically, do not use any
new drug until it has been on the market for seven years because that
is the time where most of the surprises are going to happen. Unless
you want to be part of the surprise, we urge you and physicians who
take care of you to stay away from these drugs.
We now move into the area of a topic that we focused on heavily
when we first did this book and continue to focus on heavily, and
which is often confusing to the physician and patient: the issue of
drug-induced disease. You get to be sixty or seventy and you start
losing your memory or you start developing Parkinson's disease or
you start having other problems: falling down, having hip fractures.
The tendency is to say, "Well, too bad, you are getting old. That is just
a part of growing old." However, the book includes well-documented
examples of people who had, not just age related problems, but had
adverse ,drug reactions. Some examples include: arrhythmia; causing
the death of someone; Parkinsonism in someone who really started
having Parkinsonism after a drug was prescribed and only after a wise
neurologist discovered this were they taken off the drug causing it and
the Parkinsonism vanished; memory loss.
The person who wrote the Preface to our book is Dr. Eric Larson,
a physician at the University of Washington of Seattle who discovered
and documented two clear instances of drug-induced disease. One was
reversible memory loss. A large number of drugs can cause memory
loss. If you are sixty or seventy and you start losing your memory it
may look like early Alzheimer's. And, often, it is. But often, it is an
adverse drug reaction problem and fortunately, those are all reversi-
ble. Dr. Larson also discovered the relationship between using certain
drugs and having falls and hip fractures. There are numerous exam-
ples, case examples, well-documented, of drug-induced disease. So
just focusing on this and, more broadly, this issue of one hundred
thousand deaths and two million serious adverse drug reactions: what
do we do about it?
Something should be done about drug-induced illnesses to the ex-
tent that they could be reversed entirely or largely by reducing the
dose of the drug or switching to another drug. Something should also
[Vol. 16:785
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be done to the extent that, too often, the average drug reaction, when it
appears to be a new "disease", is treated with another drug.
When we first did our book in 1988, a woman was referred to me
who was about fifty and had documented low thyroid levels. She was,
appropriately, put on a thyroid medicine to treat the low thyroid lev-
els. However, she was put on too high a dose and, for some reason,
was taking it very late in the day. As a result, she developed insomnia
and was put on a sleeping pill. Because she was on a sleeping pill, she
became depressed and was put on an antidepressant. Sleeping pills,
not infrequently, can cause depression. Thus, she was put on an anti-
depressant to treat the depression that was caused by the sleeping pill,
the need for which was caused by the way she was taking her thyroid
medicine. We arranged, with her physician, to lower the dose of thy-
roid medicine and for her to take it early in the morning instead of late
in the day. She stopped having insomnia and needing the sleeping pill.
She therefore also stopped needing the antidepressant to treat the de-
pression caused by the sleeping pill. This is an example of the sort of
cascade of drug-induced diseases being treated with drugs instead of
prevention. The book lists 166 drugs can cause depression. 156 drugs
that can cause hallucinations or psychoses.
Sexual dysfunction is an interesting issue. A year after Viagra
came on the market, I looked through the FDA's files-legally with
permission-at all of the cases of adverse reactions reported with Via-
gra. I was more interested in what other drugs these people were tak-
ing than in the actual nature of the adverse reactions. What I found
was half of the people who had an adverse reaction to Viagra were
taking one or more drugs that can cause sexual dysfunction. Whereas
this was occurring in men who were also using Viagra, many of these
same drugs, these SSRI's (Selective serotonin reuptake inhibitors),
Prozac, Zoloft and so forth, can also cause sexual dysfunction in
women. Again, if the sexual dysfunction is drug induced, the treat-
ment might more optimally be to change drugs or to lower the dose, as
opposed to taking Viagra or Levitra or Cialis, to treat what is drug-
induced sexual dysfunction.
There are other examples of drug-induced illnesses. As already
mentioned, our friend, Dr. Eric Larson, discovered well-documented,
reversible dementia in older people. Hip fractures from falling,
another category. More examples of drug-induced problems include
auto accidents, falling asleep, and insomnia. Thyroid medication,
including Synthroid, and quite a few other drugs can also cause
insomnia. Again, most of the people taking these drugs who have
insomnia are given sleeping pills, even though there should be other
ways of dealing with this. There is also the serious problem drug-
induced Parkinsonism.
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We categorize areas of problems where prescriptions are written
where they should not or where it is the wrong prescription. We call
these seven all too-often-deadly sins. This is not meant to be a reli-
gious treatise.
First, the disease for which the drug is prescribed is actually an
adverse reaction to another drug-we have just given some exam-
ples-masquerading as a disease.
Second, the drug is used to treat a problem that, although is sus-
ceptible to a prescription drug or over-the-counter drug solution,
should, first, be treated with commonsense lifestyle changes. A huge
proportion of people with mild hypertension, with mild adult onset
diabetes, with mild obesity or being overweight, should first be tried
with lifestyle changes. Unfortunately, too many physicians are not
adequately trained in nutrition or discussions about exercise and it is
much easier to just write a prescription. This is particularly so when a
drug salesperson is yelling in your ear that this is the way to take care
of these problems.
Third, the medical problem is both, self-limited and completely
unresponsive to treatments. An example is the use of antibiotics for
viral infections when no antibiotic will work at all and an antibacte-
rial, certainly, will not work. A lot of self-limited diseases, a cold be-
ing a good example, will get better in seven days with certain drugs
and in a week without certain drugs. The net impact of the certain
drugs is often really certain adverse reactions. An example is insom-
nia because some of these cold medicines have a decongestant which
is an amphetamine-like upper. We have argued for twenty-five years
no one should ever take a systemic decongestant because you are get-
ting, roughly, twenty-five times more drug than if you squirted some
spray in your nose and with all the dangers of inherent. PPA or
phenylpropanolamine, which was an ingredient in a lot of cold prepa-
rations, was taken off the market after it was shown to cause hemor-
rhagic stroke. It is an upper and increases blood pressure and can
cause strokes.
Fourth, a drug is the preferred treatment but instead of giving you
a safer alternative, one of the 181 "Do Not Use" drugs is recom-
mended. Obviously, it is not just self-serving for me to say: stay away
from "Do Not Use" drugs. There are safer alternatives.
Fifth, drugs interact. Most people, including many physicians,
have a misperception as to what a drug interaction means. It does not
mean that if you put the two drugs together an explosion occurs. What
it does usually mean is that one drug will stop the body from effi-
ciently getting rid of the other drug. So, if you take two drugs that
interact, the first one may inhibit the liver's ability to get rid of the
second drug, and therefore, you may accumulate dangerous levels of
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the second drug, not because you were prescribed dangerous levels,
but because the body could not effectively get rid of it.
Sixth, another problem is physicians who prescribe two drugs in
the same therapeutic category-sometimes it is necessary, but more
often it is not. Often, the second drug does not have any evidence of
increasing the effectiveness of the first drug but it incurs an additional
risk. Thus, there are two risks, but one benefit. This is not a good deal.
Seventh, the right drug is prescribed, but the dose is too high. This
is particularly true in older adults. We will go through some reasons
why older adults have more difficulty with prescription drugs and why
in probably 98 percent of the cases they should always be started with
a lower dose. An older adult includes me, and has included me for
more than twenty years, because some of these changes in the liver
and kidneys start at age forty or fifty.
Next are nine reasons why older adults should pay particular at-
tention to the drugs they are prescribed. Older adults have smaller
bodies and different body composition. When we get older our
weight, generally, goes down. It may seem to go in the other direction
for a while, but we have a smaller amount of water. To the extent that
a lot of the drugs are water-soluble, the same amount of drug will dis-
solve in a smaller amount of water and therefore the concentration
will be higher. There is also decreased ability of the liver to process
drugs and for the kidney to get drugs out of the body. The decrease in
kidney function starts at age thirty-five to forty and by the time we are
sixty-five, the filtering ability has decreased by 30 percent. These are
not people with kidney disease or liver disease, just people who are
aging and these two organs that are so crucial to drug metabolism or
elimination are not working as well as they used to. It gets, obviously,
much worse if you also have kidney disease or liver disease.
In addition to decreased body size and less water and higher drug
concentrations, even at normal blood levels, older people may be
much more sensitive to drugs than younger people. How many of you
who are over sixty, when you get out of bed in the morning, sit on the
edge of your bed for at least ten seconds before standing? Why is this
important? When we are younger and we get out of bed the blood
tends to rush to the bottom of our body just by gravity, but, instantly,
our more effective, younger homeostatic mechanisms constrict the
blood vessels and it happens so quickly that the blood pressure is not
allowed to fall. This does not work as well when we are older. So
either when you are getting out of bed you should sit on the edge of
the bed or when you are standing, after sitting, stand by the chair for
five or ten seconds. This is a major cause of falls and it is largely
avoidable. Compounding this though, are people who are also taking
blood pressure medicines. In addition to not being able to compensate
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for the gravitational effect, you are taking a drug which may lower
your blood pressure. Although even if you are not taking high blood
pressure drugs, it is important to do this healthy hesitation for a few
seconds.
Decreased temperature compensation is another problem that in-
creases when one is older and may be worsened if using certain pre-
scription drugs. One of the first things I did when I arrived at NIH in
1966 was to study how much water you had to drink to avoid going
into negative fluid balance when it was warm outside. It is amazing
how much sweat you can produce when it is hot. Humans would die if
they did not sweat, period. The only way we stay alive in a hot envi-
ronment, other than air-conditioning, is to sweat. It evaporates and it
cools the body. Normally, if it is very, very hot outside, we are able to
divert almost all of our fluid to sweat and thereby help us stay in good
health. Certain drugs interrupt this diversion of fluid into sweat and
force a certain amount of fluid into the urine. For diuretics, for exam-
ple, that is the way they work. When it gets very hot outside it is all
the more important to pay attention to drugs you are taking that might
cause fluid loss and to drink more liquids.
Diseases affect the body's response to drugs. I mentioned earlier
that even if you do not have liver or kidney problems those functions
decrease with age. But, if you do have these problems, they make it
even more difficult to figure out the right dose of drugs and make it
even more necessary to use lower doses. More drugs equal more ad-
verse reactions. Obviously, if you take one drug you can have an ad-
verse reaction. If you take two, the odds increase including the possi-
bility of an interaction. Many older people, however, are taking six,
seven, eight drugs. I am happy to report-she would not attack me for
saying this-that my ninety-seven-year-old mother is taking one pre-
scription drug and she is in very good health and has somehow sur-
vived without taking a lot of prescription drugs. The point is, once
you start-and obviously, many people need to take more than one
drug,-as you go up in number, you multiply the possibility for reac-
tions and interactions. It is a geometric, not an arithmetic increase in
possible interactions.
A favorite quote is about the fact that older people, who take the
most drugs, are often the least used subjects for finding out about
these drugs. Dr. Peter Lamay, who was at the University of Maryland
School of Pharmacy, who died about fifteen years ago, said, "We test
drugs in young people for three months; we give them to old people
for fifteen years." And for the reasons I have just pointed out, old
people and young people are very different in many respects.
Our book also contains ten rules for safer drug use. The first rule,
have a "brown bag session" with your primary doctor and fill
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out a drug worksheet, you all have heard of but I am not sure how
many of you have done it and do it completely. People are taking, not
only prescription drugs, but also over-the-counter drugs, and an in-
creasing number of people, unfortunately, are taking dietary supple-
ments. One of the chapters we added to this book, which had not been
in there in previous editions, was a review of thirteen of the biggest
selling dietary supplements. We found that none of the thirteen dietary
supplements would pass the test of being effective and safe if they had
to. However, because of a law, which Congress passed, dietary sup-
plements do not have to be shown to be safe or effective. And compa-
nies do not have to report deaths or any adverse reactions. But the
people who take these on their own, as is the case for over-the-counter
drugs, often are embarrassed to tell or do not tell their physicians. So,
the first rule is to let your physician, and hopefully it is a primary care
physician which is what rule ten is, know everything that you are us-
ing because the odds are that they may say, "Wait a minute, this inter-
acts with this. You probably should not be using one of them." And
the most dispensable one would be dispensed with.
Rule two is to make sure drug therapy is really needed. This is a
corollary of what I said earlier that a lot of times, problems that are
either self limited or problems that could benefit from non-
pharmacological solutions are immediately treated with drugs.
Rule three, if drug therapy is indicated, in most cases, especially
in older adults, start with a lower dose and go slowly up. This is much
safer than starting with a higher dose and getting an unnecessary ad-
verse reaction. Many people are taking five, six, seven drugs and the
most dispensable of those should be the one that maybe is stopped if it
is really necessary to take another drug that really is critical.
Rule five is that stopping a drug is as important as starting it. For
reasons we do not fully understand, in many who have been taking an
anti-hypertension drug for several years, their need decreases. Peri-
odically attempt, with a physician, to lower the dose of an anti-
hypertensive drug and you will many times see that the blood pressure
stays the same and when you lower it down to nothing, it may still
stay the same. Not something you should do on your own but a way
of, again, reducing exposure to drugs.
Rule six is to find out if you are having any adverse drug reac-
tions. Studies thirty-five years ago, and recently, show that many phy-
sicians, a majority, do not adequately inform people about known
risks of prescription drugs. Thus, when the person takes the drug and
develops what is, in fact, an adverse drug reaction, they think, well,
maybe this is just a turn for the worse in my disease and they do not
make the connection and therefore, do not call the physician and
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therefore, have a longer period of adverse drug reactions than they
should.
Rule seven is probably as important as any, which is once you
start taking a new drug and you develop a new symptom, the default
should be: this is an adverse drug reaction until proven otherwise. If
you have books or information that point this out fine, but in any
event tell your physician about it because this may be the beginning of
what is a serious adverse reaction and you and your physician should
possibly lower the dose or switch away from that drug. This is par-
ticularly true for older people but even some younger people.
Rule number eight is that before leaving the doctor's office make
sure that you know how to take the medicine and the issue of adverse
reactions are clear to you and a family member or friend.
Rule number nine is: discard all drugs carefully. There was actu-
ally, not funny but it was, at some level, an amusing article on the
front page of the New York Times this morning, long after we pro-
posed this rule, which is seventeen years old. The article in the Times
was about a whole circle of trading drugs among friends. This is dan-
gerous because someone may not have the disease that the amateur
physician thinks that they have and they might have a very bad reac-
tion to the drug. Someone may be taking another drug unbeknownst to
the drug-hander-outer. So, discard all old drugs carefully is a good
rule.
Finally, as I mentioned before, rule number ten is that everyone
needs to have a primary-care doctor. This is not self-serving because I
am a primary-care general internist, but because too often, older
people wind up going to the kidney doctor, the heart doctor, the
gastrointestinal doctor and the neurologist and no one is coordinating
the care leading people to get prescriptions for drugs that if one doctor
knew about what the others are prescribing the drug would never all
be prescribed.
Another section of the book advises how people can save money
when buying prescriptions. Five rules include asking, if appropriate,
for non-drug treatment. These rules are, obviously, overlapping with
some of the lists of suggestions discussed above. Avoid "Do Not Use"
drugs. Over the years, many of the drugs that we said "Do Not Use"
have been taken off the market. As I mentioned before, because of the
study we did and because of other evidence, do not use new drugs
unless they are a breakthrough drug for at least seven years. By then,
by definition, they will be safer if they are still on the market and, at
least, you will know through a black box warning about some of the
newly discovered problems.
Buy generic drugs. There is no evidence, whatsoever, that generic
drugs are any less effective or safe than brand name drugs. More and
[Vol. 16:785
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more expensive brand name drugs are coming off patent. You should
use generic drugs. Finally, we think that purchasing drugs from Can-
ada and importing them or using Internet purchase can be very good
but you have to be very careful. There are a lot of charlatans in this
country who have web sites where you do not need to have a doctor
and there is only a computer version of a pharmacist that actually does
the prescribing and dispensing and, unfortunately, the medical boards
and the pharmacy boards have not disciplined the physicians and
pharmacists who are lending their names to these web sites as much as
they should.
In thirty-four years, we've asked the FDA to ban twenty-seven
prescription drugs. Two-thirds of them, or eighteen, are off the market
now. Another four, the use is severely limited and five of them, or
nearly 20 percent, are still on the market. These are, mainly, recently
approved drugs like Celebrex and Crestor. We tried to get the FDA to
ban Celebrex at the same time we tried to get them to ban Bextra.
Although they have left Celebrex on the market, this is a mistake be-
cause it has increased cardiovascular risks as well.
This year, through an act of Congress that was passed thirteen
years ago called the Prescription Drug User Fee Act, the FDA gets
more than $200 million in cash directly from the drug industry to fund
a good proportion of its drug review functions. Those who say it does
not have any influence on the FDA to get funded from the industry
that it is supposed to be regulating it are wrong. There are lots of peo-
ple, physicians and others in the FDA, who are starting to think that
their client is not the public entirely, which is what should be, but it is
also the industry. The lax FDA behavior since this law was passed,
accompanied by sharply decreased congressional oversight, has led
the FDA to be far less vigilant than it used to be in the 70s and 80s,
when I first started doing this work.
Finally, a little bit on advertising. The Garden of Folly is a won-
derful, short book written by a Canadian economist, Stephen Leacock,
eighty-one years ago. The "folly" is advertising and it includes the
most poignant definition of advertising I have ever seen. "The science
of arresting the human intelligence long enough to get money from
it." This idea is not just relevant to direct-to-consumer advertising to
patients, but also to advertising and promotion of drugs to physicians
with as much misleading information as the companies can get away
with.
We have been tracking, for more than a decade, the FDA's en-
forcement activities over prescription drug advertising. Either in the
form of warning letters or other letters, the FDA enforces the law and
regulations concerning prescription drug advertising by notifying drug
companies that they must stop certain ads because the are illegal. The
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legal bases for which these ads are deemed illegal include overstating
the benefits, understating the risks and not having an adequate balance
between benefits and risks. 1998, at the peak of FDA's activity in this
area, they stopped 157 illegal prescription drug ads. The amount of
drug ads has rocketed since then. So, if the ads were no better, no
worse than they were in 1998, one would expect a big increase in the
number of enforcement actions. Instead, during the Clinton admini-
stration, the number of enforcement actions started rocketing down,
significantly, to the point where last year, 2004, it was down to
twenty-four, an 85 percent decrease in the amount of activity that the
FDA is exerting through the law and regulations that they are sup-
posed to be upholding. And the message to the industry is that they
can just mislead people. Of course, a misleading ad may result in a
dead patient because if a physician prescribes a drug based on think-
ing the drug is safer and/or more effective than it really is, the doctor
may write a prescription for something they would not have written
for if they had been adequately informed. So, advertising enforcement
is very, very important.
In his introduction to Worst Pills, Best Pills, Dr. Eric Larson has
said that although we are, appropriately, harsh with those drugs that
we designate as DO NOT USE, we are not inappropriately harsh so
that patients should be hopeless or cynical. One should use the infor-
mation to tell the difference between the best bills-the safer, equally
or more effective pills-and the ones you should stay away from, the
worst pills.
Over the years, we have warned patients to stop using certain
dangerous drugs as long as several years before they were banned.
Vioxx is such an example, wherein we told people to stop using the
drug in early 2001, more than three years before it was pulled off the
market. Another is the cholesterol-lowering drug, Baycol. When we
make these "do not use" recommendations, we base our conclusions
on data, often unpublished data, that we got from the FDA, sometimes
having to sue them to force some of these company studies to be re-
leased. So, over and over again, we have predicted, usefully-for
those people that get this information-the dangers of a drug before
we have, through the regulatory part of our work, gotten the FDA to
ban them.
All of the contents of our book Worst Pills, Best Pills, our
monthly newsletter Worst Pills, Best Pills News, and drug safety alerts
are now on our web site Worstpills.org.
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